Coronary heart disease and HRT in France: MISSION study prospective phase results

References

• Barrett-Connor E. Hormones and heart disease in women: the timing hypothesis. Am J Epidemiol 2007; 166: 506–510
   PubMed Web of Science ®Google Scholar
• Grady D, Rubin S M, Petitti D B, Fox C S, Black D, Ettinger B, Ernster V L, Cummings S R. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 1992; 117: 1016–1037
   PubMed Web of Science ®Google Scholar
• Barret-Connor E, Grady D. Hormone replacement therapy, heart disease, and other considerations. Annu Rev Public Health 1998; 19: 55–72
   PubMed Web of Science ®Google Scholar
• Roussouw J E, Anderson G L, Prentice R L, LaCroix A Z, Kooperberg C, Stefanick M L, Jackson R D, Beresford S A, Howard B V, Johnson K C, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321–333
   PubMed Web of Science ®Google Scholar
• Grady D, Herrington D, Bittner V, Blumenthal R, Davidson M, Hlatky M, Hsia J, Hulley S, Herd A, Khan S, et al. Cardiovascular outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERS II). JAMA 2002; 288: 49–57
   PubMed Web of Science ®Google Scholar
• Anderson G L, Limacher M, Assaf A R, Bassford T, Beresford S A, Black H, Bonds D, Brunner R, Brzyski R, Caan B, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701–1712
   PubMed Web of Science ®Google Scholar
• Manson J E, Hsia J, Johnson KC Rossouw J E, Assaf A R, Lasser N L, Trevisan M, Black H R, Heckbert S R, Detrano R, et al. Estrogen plus progestin and the risk of coronary heart disease. N Engl J Med 2003; 349: 523–534
   PubMed Web of Science ®Google Scholar
• Salpeter S R, Walsh J ME, Greyber E, Salpeter E E. Coronary heart disease events associated with hormone therapy in younger and older women. JGIM 2006; 21: 363–366
   PubMed Web of Science ®Google Scholar
• Grodstein F, Manson J E, Stampfer M J. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation. J Womens Health 2006; 15: 35–44
   PubMed Web of Science ®Google Scholar
• Hsia J, Langer R D, Manson J E, Kuller L, Johnson K C, Hendrix S L, Pettinger M, Heckbert S R, Greep N, Crawford S, et al. Conjugated equine estrogene and coronary heart disease. Arch Intern Med 2006; 166: 357–365
   PubMed Web of Science ®Google Scholar
• Chevallier T, Daures J P, Micheletti M C, Reginster J Y, Groupe M ISSION. Méthodologie de l'enquête MISSION (Ménopause,rISque de cancer du SeIn, mOrbidité et prévaleNce). J Gynecol Obstet Biol Reprod 2005; 34: 658–665
   PubMedGoogle Scholar
• Genazzani A R, Gambacciani M, Simoncini T. Italian position on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), 8–9 May 2007. Gynecol Endocrinol 2007; 23: 436–444
   PubMed Web of Science ®Google Scholar
• Clarkson T B, Hughes C L, Klein K P. The nonhuman primate model of the relationship between gonadal steroids and coronary heart disease. Prog Cardiovasc Dis 1995; 38: 189–198
   PubMed Web of Science ®Google Scholar
• Pines A, Sturdee D W, Birkhäuser M H, Schneider H PG, Gambacciani M, Panary N. IMS updated recommendations on postmenopausal hormone therapy. Climacteric 2007; 10: 181–194
   PubMed Web of Science ®Google Scholar
• Windler E, Zyriax B C, Eidenmüller B, Boeing H. Hormone replacement therapy and risk for coronary heart disease data from the CORA-study- A case-control study on women with incident coronary heart disease. Maturitas 2007; 57: 239–249
   PubMed Web of Science ®Google Scholar
• Vitale C, Mercuro G, Cerquentani E, Marazzi G, Patrizi R, Pelliccia F, Volterrani M, Fini M, Collins P, Rosano G M. Time since menopause influences the acute and chronic effects of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2007; 28: 348–352
   PubMed Web of Science ®Google Scholar
• Miller V M, Jayachandran M, Owen W G. Ageing, oestrogen, platelets and thrombotic risk. Clin Exp Pharmacol Physiol 2007; 34: 814–821
   PubMed Web of Science ®Google Scholar
• Sonnet E, Lacut K, Roudaut N, Mottier D, Kerlan V, Ogert E. Effects of the route of oestrogen administration on IGF-1 and IGFBP-3 in healthy postmenopausal women: result from a randomized placebo-controlled study. Clin Endocrinol 2007; 66: 626–631
   PubMed Web of Science ®Google Scholar
• Marfella R, Di Fillipo C, Portoghese M, Ferraraccio F, Crescenzi B, Siniscalchi M, Barbieri, Bologna, Rizzo M R, Rossi F, et al. Proteasome activity as a target of hormone replacement therapy dependent plaque stabilization in postmenopausal women. Hypertension 2008; 51: 1135–1141
   PubMed Web of Science ®Google Scholar
• Espie M, Daures J P, Chevallier T Mares P, Micheletti M C, De Reilhac P. Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase. Gynecol Endocrinol 2007; 23: 391–397
   PubMed Web of Science ®Google Scholar